Breaking News

Merck KGaA, Maker of Erbitux Cancer Drug, to Acquire Sigma-Aldrich for $17 Billion
Tweet TWEET

DuPont Reports 1Q 2013 Operating EPS of $1.56

                DuPont Reports 1Q 2013 Operating EPS of $1.56

Agriculture Segment Achieves Record Operating Earnings, Company Raises
Dividend

PR Newswire

WILMINGTON, Del., April 23, 2013

WILMINGTON, Del., April 23, 2013 /PRNewswire/ --DuPont (NYSE: DD)today
announced first quarter 2013 operating earnings per share (EPS) of $1.56
versus prior year earnings of $1.64. GAAP^1 EPS from continuing operations
was $1.47 versus $1.48 in the prior year. Primary drivers of results for the
quarter were record Agriculture operating earnings offset by an expected
decline in Performance Chemicals. DuPont reaffirmed its full year 2013 EPS
outlook and today announced a 5 percent dividend increase.

1Q 2013 Highlights
- Sales of $10.4 billion were up 2 percent, reflecting volume growth. A one
percent increase in local prices
 was offset by currency impact.
- Record Agriculture operating earnings of $1.5 billion were up 13 percent.
Sales increased 14percent
 driven by strong volume growth, particularly in North America and Latin
America, and higher pricing
 from new seed and crop protection products.
- Total segment operating earnings of $2.3 billion were down 8 percent,
largely due to a $320 million decline
 (about $.26 EPS) in Performance Chemicals from last year's high levels.
- The company completed the sale of the Performance Coatings segment, executed
a $1 billion share
buyback and reduced its net debt.
- Cost productivity gains and restructuring savings are on track to meet or
exceed full year targets.
- The company reaffirms its outlook for full-year 2013 operating earnings of
$3.85-$4.05 per share, an
 increase of 2-7 percent from $3.77 per share earned in 2012.

"The first quarter finished as expected, with the strong Agriculture
performance and Performance Chemicals' decline from peak levels last year,"
said DuPont Chair and CEO Ellen Kullman. "Our strategies for growth and
improved return on capital are working as we continue to focus on delivering
science-powered innovation and industry-leading productivity improvement. We
remain committed to delivering value to our shareholders as demonstrated by
executing our share buyback, strengthening our balance sheet and increasing
our dividend."

Global Consolidated Sales – 1st Quarter
First quarter 2013 sales were $10.4 billion, up 2 percent versus last year,
with 2 percent higher volume. Negative currency impact offset higher local
selling prices. Volume was primarily driven by increases for Agriculture in
North America and Latin America. The table below shows first quarter regional
sales and variances versus first quarter 2012.

                          Three Months Ended   Percentage Change Due to:
                          March 31, 2013
(Dollars in millions)     $          % Change  Local    Currency  Volume
                                               Price    Effect
U.S. & Canada             $  4,848  8         4        -         4
EMEA*                     2,727      (1)       1        (1)       (1)
Asia Pacific              1,754      (8)       (6)      (2)       -
Latin America             1,079      4         4        (4)       4
Total Consolidated Sales  $ 10,408   2         1        (1)       2
* Europe, Middle East & Africa

Segment Sales – 1st Quarter
The table below shows first quarter 2013 segment sales with related variances
versus the prior year.

SEGMENT SALES                 Three Months Ended     Percentage Change
(Dollars in millions)         March 31, 2013         Due to:
                              $            % Change  USD    Volume  Portfolio/
                                                     Price          Other
Agriculture                   $   4,669  14        6      8       -
Electronics & Communications 616          (9)       (3)    (6)     -
Industrial Biosciences        289          -         1      (1)     -
Nutrition & Health            868          7         5      4       (2)
Performance Chemicals         1,585        (17)      (11)   (6)     -
Performance Materials         1,559        (3)       (3)    1       (1)
Safety & Protection           907          (4)       (2)    (2)     -
Other                         1            nm
Total segment sales           10,494
Elimination of transfers      (86)
Consolidated net sales        $  10,408



Operating Earnings – 1st Quarter

                                                            Change vs. 2012
(Dollars in millions)              1Q13         1Q12        $             %
Agriculture                       $  1,516   $  1,338   $    178   13%
Electronics & Communications       49           59          (10)          -17%
Industrial Biosciences             41           39          2             5%
Nutrition & Health                 76           79          (3)           -4%
Performance Chemicals              251          571         (320)         -56%
Performance Materials              292          277         15            5%
Safety & Protection                138          159         (21)          -13%
Other                              (91)         (76)        (15)          nm
                                   2,272        2,446       (174)         -7%
Pharmaceuticals                   4            27          (23)          -85%
Total segment operating earnings   2,276        2,473       (197)         -8%
^(1)
Corporate expenses                 (214)        (251)       37            -15%
Interest expense                   (117)        (114)       (3)           3%
Operating earnings before income   1,945        2,108       (163)         -8%
taxes and exchange gains/losses
Provision for income taxes on
operating earnings, excluding      (456)        (505)       49            nm
taxes
 on exchange gains/losses
Net after-tax exchange gains       (23)         (44)        21            nm
(losses) ^(2)
Net income attributable to         (7)          (12)        5             nm
noncontrolling interests
Operating earnings               $  1,459   $  1,547   $    (88)  -6%
Operating earnings per share       $   1.56  $   1.64  $  (0.08)   -5%
(1) See Schedules B and C for listing of significant items and their
impact by segment.
(2) See Schedule D for additional information on exchange gains and
losses.



The following is a summary of business results for each of the company's
reportable segments in the first quarter comparing current period with the
prior year. References to selling price are on a U.S. dollar basis, including
the impact of currency.

Agriculture – Operating earnings of $1.5 billion improved 13 percent on higher
volume and price, partially offset by higher seed input costs which pressured
margin slightly. Earnings improvement was driven by a 14 percent increase in
sales reflecting strong corn seed sales in North America and Brazil and strong
Crop Protection volumes in North America and Latin America.

Electronics & Communications – Operating earnings of $49 million declined $10
million driven largely by lower sales in photovoltaic markets, as share gains
were more than offset by lower usage of materials per photovoltaic module.

Industrial Biosciences – Operating earnings of $41 million were up 5 percent
on higher demand and lower input costs for Sorona^®polymer for carpeting and
growth in food enzymes, partially offset by lower enzyme demand for ethanol
production. 

Nutrition & Health –  Operating earnings of $76 million decreased $3 million.
Pricing gains, strong demand for probiotics and specialty protein solution
and the realization of integration synergies were offset by higher raw
material costs, primarily in enablers.

Performance Chemicals – Operating earnings of $251 million were $320 million
lower, due primarily to substantial price declines in the titanium dioxide
market and weak demand for fluoropolymers, particularly in North America and
Asia Pacific. Titanium dioxide volume was essentially flat year-over-year,
but increased 8 percent from fourth quarter 2012.

Performance Materials – Operating earnings of $292 million increased 5 percent
due primarily to lower feedstock costs and higher sales volume in packaging
markets, partially offset by weak demand in the European automotive market and
continued softness in the industrial and electronics markets.

Safety & Protection – Operating earnings of $138 million decreased $21 million
reflecting a weaker sales mix, as well as lower plant utilization. Lower
sales primarily reflect significantly reduced demand for military protection
products and continued softness in certain industrial markets. 

Additional information is available on the DuPont Investor Center website at
http://www.investors.dupont.com.

Outlook
The company reaffirms its outlook for full-year 2013 operating earnings of
$3.85-$4.05 per share, an increase of 2-7 percent from $3.77 per share earned
in 2012,based on continued strong growth in Agriculture and anticipated
overall improvement in global industrial market demand. For first-half 2013,
the company expectsoperating earnings per share to be about 7-9 percent lower
than the first half of 2012, primarily reflecting, as in the first quarter,
lower Performance Chemicals earnings from peak levels in the prior year.

Use of Non-GAAP Measures
Management believes that certain non-GAAP measurements are meaningful to
investors because they provide insight with respect to ongoing operating
results of the company. Such measurements are not recognized in accordance
with GAAP and should not be viewed as an alternative to GAAP measures of
performance. Reconciliations of non-GAAP measures to GAAP are provided in
schedules A, C and D.

DuPont (NYSE: DD) has been bringing world-class science and engineering to the
global marketplace in the form of innovative products, materials, and services
since 1802. The company believes that by collaborating with customers,
governments, NGOs, and thought leaders we can help find solutions to such
global challenges as providing enough healthy food for people everywhere,
decreasing dependence on fossil fuels, and protecting life and the
environment. For additional information about DuPont and its commitment to
inclusive innovation, please visit http://www.dupont.com.

Forward-Looking Statements: This news release contains forward-looking
statements which may be identified by their use of words like "plans,"
"expects," "will," "believes," "intends," "estimates," "anticipates" or other
words of similar meaning. All statements that address expectations or
projections about the future, including statements about the company's growth
strategy, product development, regulatory approval, market position,
anticipated benefits of acquisitions, outcome of contingencies, such as
litigation and environmental matters, expenditures and financial results, are
forward-looking statements. Forward-looking statements are not guarantees of
future performance and are based on certain assumptions and expectations of
future events which may not be realized. Forward-looking statements also
involve risks and uncertainties, many of which are beyond the company's
control. Some of the important factors that could cause the company's actual
results to differ materially from those projected in any such forward-looking
statements are: fluctuations in energy and raw material prices; failure to
develop and market new products and optimally manage product life cycles;
significant litigation and environmental matters; failure to appropriately
manage process safety and product stewardship issues; changes in laws and
regulations or political conditions; global economic and capital markets
conditions, such as inflation, interest and currency exchange rates; business
or supply disruptions; security threats, such as acts of sabotage, terrorism
or war, weather events and natural disasters; inability to protect and enforce
the company's intellectual property rights; and integration of acquired
businesses and completion of divestitures of underperforming or non-strategic
assets or businesses. The company undertakes no duty to update any
forward-looking statements as a result of future developments or new
information.

4/23/13

^1Generally Accepted Accounting Principles (GAAP)





E. I. du Pont de Nemours and Company

Consolidated Income Statements

(Dollars in millions, except per share amounts)
SCHEDULE A
                                  Three Months Ended
                                  March 31,
                                  2013               2012
Net sales                         $     10,408   $     10,180
Other income, net^               92                 14
Total                             10,500             10,194
Cost of goods sold and other      7,105              6,816
operating charges ^(a)
Selling, general and              983                955
administrative expenses
Research and development          521                508
expense
Interest expense                 117                114
Total                             8,726              8,393
Income from continuing            1,774              1,801
operations before income taxes
Provision for income taxes on     387                392
continuing operations ^(a)
Income from continuing            1,387              1,409
operations after income taxes
Net income from discontinued      1,968              95
operations after taxes
Net income                       3,355              1,504
Less: Net income attributable    7                  12
to noncontrolling interests
Net income attributable to        $      3,348  $     
DuPont                                            1,492
Basic earnings per share of
common stock ^(b):
Basic earnings per share of       $            $      
common stock from continuing      1.48               1.49
operations
Basic earnings per share of
common stock from discontinued    2.12               0.10
operations
Basic earnings per share of       $            $      
common stock                      3.60               1.60
Diluted earnings per share of
common stock ^(b):
Diluted earnings per share of     $            $      
common stock from continuing      1.47               1.48
operations
Diluted earnings per share of
common stock from discontinued    2.10               0.10
operations
Diluted earnings per share of     $            $      
common stock                      3.58               1.58
Dividends per share of common     $            $      
stock                          0.43               0.41
Average number of shares
outstanding used in earnings per
share (EPS) calculation:
 Basic                           928,348,000        933,910,000
 Diluted                         935,390,000        944,238,000
(a) See Schedule B for detail of
significant items.
(b) The sum of the individual
earnings per share amounts may
not equal the total due to
rounding.
Reconciliation of Non-GAAP
Measures
Summary of Earnings Comparison
                                  Three Months Ended
                                  March 31,
                                  2013               2012               %
                                                                        Change
Income from continuing                               $     
operations after income taxes     $      1,387  1,409             -2%
(GAAP)
Less: Significant items benefit
(charge) included in income from
continuing operations after       20                 (32)
income taxes (per Schedule B)
Non-operating pension/OPEB costs
included in income from
continuing operations after       (99)               (118)
income taxes
Net income attributable to        7                  12
noncontrolling interest
Operating earnings               $      1,459  $             -6%
                                                     1,547
EPS from continuing operations    $            $            -1%
(GAAP)                            1.47               1.48
Significant items benefit
(charge) included in EPS (per     0.02               (0.04)
Schedule B)
Non-operating pension/OPEB costs  (0.11)             (0.12)
included in EPS
Operating EPS                     $            $            -5%
                                  1.56               1.64







E. I. du Pont de Nemours and Company

Condensed Consolidated Balance Sheets

(Dollars in millions, except per share amounts)
SCHEDULE A (continued)
                                          March 31,          December 31,
                                          2013               2012
Assets
Current assets
Cash and cash equivalents                 $      6,555  $      4,284
Marketable securities                     26                 123
Accounts and notes receivable, net       7,950              5,452
Inventories                              6,916              7,565
Prepaid expenses                          268                204
Deferred income taxes                    699                613
Assets held for sale                      -                  3,076
Total current assets                      22,414             21,317
Property, plant and equipment, net of
accumulated depreciation                  12,590             12,741
 (March 31, 2013 - $19,233; December
31, 2012 - $19,085)
Goodwill                                  4,543              4,616
Other intangible assets                  4,970              5,126
Investment in affiliates                  1,169              1,163
Deferred income taxes                    3,957              3,936
Other assets                              921                960
Total                                     $     50,564   $     49,859
Liabilities and Equity
Current liabilities
Accounts payable                          $      3,957  $      4,853
Short-term borrowings and capital lease   2,006              1,275
obligations
Income taxes                             945                343
Other accrued liabilities                 4,615              5,997
Liabilities related to assets held for    -                  1,084
sale
Total current liabilities                 11,523             13,552
Long-term borrowings and capital lease    11,279             10,465
obligations
Other liabilities                         14,526             14,687
Deferred income taxes                     921                856
Total liabilities                         38,249             39,560
Commitments and contingent liabilities
Stockholders' equity
Preferred stock                           237                237
Common stock, $0.30 par value;
1,800,000,000 shares authorized;
 Issued at March 31, 2013 -             302                306
1,007,234,000; December 31, 2012 -
1,020,057,000
Additional paid-in capital                10,394             10,655
Reinvested earnings                       16,709             14,383
Accumulated other comprehensive loss     (8,662)            (8,646)
Common stock held in treasury, at cost
(87,041,000 shares                        (6,727)            (6,727)
 at March 31, 2013 and December 31,
2012)
Total DuPont stockholders' equity         12,253             10,208
Noncontrolling interests                  62                 91
Total equity                              12,315             10,299
Total                                     $     50,564   $     49,859







E. I. du Pont de Nemours and Company

Condensed Consolidated Statement of Cash Flows

(Dollars in millions)
SCHEDULE A (continued)
                                            Three Months Ended
                                            March 31,
Total Company                               2013              2012
Net income                                  $     3,355  $     1,504
Adjustments to reconcile net income to cash
used for operating activities:
Depreciation                                327               349
Amortization                                106               106
Other noncash charges and credits - net     (23)              311
Gain on sale of business                    (2,683)           -
Contributions to pension plans              (110)             (614)
Change in operating assets and liabilities  (3,639)           (3,533)
- net
Cash provided by (used for) operating       $    (2,667)  $    (1,877)
activities
Investing activities
Purchases of property, plant and equipment  (321)             (301)
Proceeds from sale of business              4,815             -
Net (increase) decrease in short-term       99                248
financial instruments
Forward exchange contract settlements       (47)              (87)
Other investing activities - net            62                (16)
Cash provided by (used for) investing       4,608             (156)
activities
Financing activities
Dividends paid to stockholders              (405)             (386)
Net increase (decrease) in borrowings       1,558             2,278
Prepayment for the repurchase of common     (1,000)           (400)
stock
Proceeds from exercise of stock options     117               389
Other financing activities - net            61                (36)
Cash provided by (used for) financing       331               1,845
activities
Effect of exchange rate changes on cash     (96)              12
Increase (decrease) in cash and cash        2,176             (176)
equivalents
Cash and cash equivalents at beginning of   4,379             3,586
period
Cash and cash equivalents at end of period  $     6,555  $     3,410
Reconciliation of Non-GAAP Measure
Calculation of Free Cash Flow - Total
Company
                                            Three Months Ended
                                            March 31,
                                            2013              2012
Cash provided by (used for) operating       $    (2,667)  $    (1,877)
activities
Purchases of property, plant and equipment  (321)             (301)
Free cash flow                              $    (2,988)  $    (2,178)







E. I. du Pont de Nemours and Company

Schedule of Significant Items from Continuing Operations

(Dollars in millions, except per share amounts)
SCHEDULE B
SIGNIFICANT ITEMS FROM CONTINUING
OPERATIONS
              Pre-tax                After-tax           ($ Per Share)
              2013        2012       2013      2012      2013        2012
1st Quarter
Customer      $         $        $       $       $         $  
claims charge (35)       (50)      (22)     (32)     (0.02)     (0.04)
^(a)
Income tax    -           -          42        -         0.04        -
items ^(b)
1st Quarter - $         $        $      $       $        $  
Total         (35)       (50)      20       (32)     0.02       (0.04)
        First quarter 2013 and first quarter 2012 included charges of $(35)
        and $(50), respectively, recorded in Cost of goods sold and other
        operating charges associated with the company's process to fairly
        resolve claims related to the use of Imprelis® herbicide, bringing the
        total charges to $(785) at March 31, 2013. The company will continue
        to evaluate reported claim damage as additional information becomes
        available. It is reasonably possible that additional charges could
(a)     result from this evaluation. While there is a high degree of
        uncertainty, total charges could range as high as $(900). The company
        has an applicable insurance program with a deductible equal to the
        first $100 of costs and expenses. The insurance program limits are
        $725 for costs and expenses in excess of the $100. The company has
        submitted and will continue to submit requests for payment to its
        insurance carriers for costs associated with this matter. The process
        of seeking insurance recovery is ongoing and the timing and outcome
        are uncertain. This matter relates to the Agriculture segment.
        First quarter 2013 included a net tax benefit of $42 consisting of a
(b)     $68 benefit for the 2013 extension of certain U.S business tax
        provisions offset by a ($26) charge related to the global distribution
        of Performance Coatings cash proceeds.







E. I. du Pont de Nemours and Company

Consolidated Segment Information

(Dollars in millions)
SCHEDULE C
                                   Three Months Ended
                                   March 31,
SEGMENT SALES ^(1)                 2013        2012
Agriculture                        $  4,669  $  4,080
Electronics & Communications       616         677
Industrial Biosciences             289         288
Nutrition & Health                 868         808
Performance Chemicals              1,585       1,900
Performance Materials              1,559       1,600
Safety & Protection                907         941
Other                              1           1
Total Segment sales                10,494      10,295
Elimination of transfers           (86)        (115)
Consolidated net sales             $ 10,408   $ 10,180
(1) Sales for the reporting segments include transfers.







E. I. du Pont de Nemours and Company

Consolidated Segment Information

(Dollars in millions)
SCHEDULE C (continued)
                                                     Three Months Ended
                                                     March 31,
INCOME/(LOSS) FROM CONTINUING OPERATIONS (GAAP)      2013          2012
Agriculture                                         $  1,481    $  1,288
Electronics & Communications                         49            59
Industrial Biosciences                               41            39
Nutrition & Health                                   76            79
Performance Chemicals                                251           571
Performance Materials                                292           277
Safety & Protection                                  138           159
Pharmaceuticals                                     4             27
Other                                                (91)          (76)
Total Segment PTOI                                   2,241         2,423
Corporate expenses                                   (214)         (251)
Interest expense                                     (117)         (114)
Non-operating pension/OPEB costs                     (147)         (176)
Net exchange gains (losses) ^(1)                     11            (81)
Income before income taxes from continuing           $  1,774    $  1,801
operations
                                                     Three Months Ended
                                                     March 31,
SIGNIFICANT ITEMS BY SEGMENT (PRE-TAX) ^(2)          2013          2012
Agriculture                                         $    (35)  $   (50)
Electronics & Communications                         -             -
Industrial Biosciences                               -             -
Nutrition & Health                                   -             -
Performance Chemicals                                -             -
Performance Materials                                -             -
Safety & Protection                                  -             -
Pharmaceuticals                                     -             -
Other                                                -             -
Total significant items by segment                   (35)          (50)
Corporate expenses                                   -             -
Total significant items before income taxes          $    (35)  $   (50)
                                                     Three Months Ended
                                                     March 31,
OPERATING EARNINGS                                   2013          2012
Agriculture                                         $  1,516    $  1,338
Electronics & Communications                         49            59
Industrial Biosciences                               41            39
Nutrition & Health                                   76            79
Performance Chemicals                                251           571
Performance Materials                                292           277
Safety & Protection                                  138           159
Pharmaceuticals                                     4             27
Other                                                (91)          (76)
Total segment operating earnings                     2,276         2,473
Corporate expenses                                   (214)         (251)
Interest expense                                     (117)         (114)
Operating earnings before income taxes and exchange  1,945         2,108
gains (losses)
Net exchange gains (losses) ^(1)                     11            (81)
Operating earnings before income taxes               $  1,956    $  2,027
(1) See Schedule D for additional information on exchange gains and losses.
(2) See Schedule B for detail of significant items.







E. I. du Pont de Nemours and Company

Reconciliation of Non-GAAP Measures

(Dollars in millions, except per share amounts)
SCHEDULE D
Reconciliations of Adjusted EBIT / EBITDA to Consolidated Income Statements
                                                     Three Months Ended
                                                     March 31,
                                                     2013          2012
Income from continuing operations before income      $        $     
taxes                                                 1,774      1,801
Less: Net income attributable to noncontrolling      7             12
interests
Add: Interest expense                              117           114
Adjusted EBIT from continuing operations             1,884         1,903
Add: Depreciation and amortization                  433           427
Adjusted EBITDA from continuing operations           $        $     
                                                      2,317      2,330
Reconciliation of Operating Earnings Per Share (EPS) Outlook
The reconciliation below represents the company's outlook on an operating
earnings basis, defined as earnings from continuing operations excluding
significant items and non-operating pension/OPEB costs.
                                                     Year Ended December 31,
                                                     2013 Outlook  2012 Actual
Operating EPS                                        $3.85 -      $     
                                                     $4.05         3.77
Significant items
Tax items                                            0.04          -
Sale of an equity method investment                  -             0.08
Customer claims charges                              (0.02)        (0.39)
Restructuring charge/adjustments                     -             (0.17)
Litigation settlement                                -             (0.13)
Asset impairment charge                              -             (0.19)
Sale of business                                     -             0.08
Non-operating pension/OPEB costs - estimate          (0.42)        (0.46)
Impact of LIFO accounting change                     -             0.02
EPS from continuing operations (GAAP)                $3.45 -      $     
                                                     $3.65         2.61







E. I. du Pont de Nemours and Company

Reconciliation of Non-GAAP Measures

(Dollars in millions)
SCHEDULE D (continued)
Exchange Gains/Losses on Operating Earnings
The company routinely uses forward exchange contracts to offset its net
exposures, by currency, related to the foreign currency denominated
monetary assets and liabilities of its operations. The objective of
this program is to maintain an approximately balanced position in
foreign currencies in order to minimize, on an after-tax basis, the
effects of exchange rate changes. The net pre-tax exchange gains and
losses are recorded in Other income, net and the related tax impact is
recorded in Provision for (benefit from) income taxes on the
Consolidated Income Statements.
                                               Three Months Ended March
                                               31,
                                               2013          2012
Subsidiary/Affiliate Monetary Position Gain
(Loss)
Pre-tax exchange gains (losses) (includes      $          $    
equity affiliates)                             (95)          47
Local tax benefits (expenses)                  3             (7)
Net after-tax impact from subsidiary           $          $    
exchange gains (losses)                        (92)          40
Hedging Program Gain (Loss)
Pre-tax exchange gains (losses)                $    106   $  
                                                             (128)
Tax benefits (expenses)                        (37)          44
Net after-tax impact from hedging program      $         $   
exchange gains (losses)                        69            (84)
Total Exchange Gain (Loss)
Pre-tax exchange gains (losses)                $         $   
                                               11            (81)
Tax benefits (expenses)                        (34)          37
Net after-tax exchange gains (losses) ^(1)     $          $   
                                               (23)          (44)
As shown above, the "Total Exchange Gain (Loss)" is the sum of the
"Subsidiary/Affiliate Monetary Position Gain (Loss)" and the
"Hedging Program Gain (Loss)."
(1) The above Net after-tax exchange gains (losses) excludes gains
(losses) attributable to discontinued operations of ($5) and $0 for
the three months ended March 31, 2013 and 2012, respectively.
Reconciliation of Base Income Tax Rate to Effective Income Tax Rate
Base income tax rate is defined as the effective income tax rate less
the effect of exchange gains (losses), as defined above, significant
items and non-operating pension/OPEB costs.
                                               Three Months Ended March
                                               31,
                                               2013          2012
Income from continuing operations before       $  1,774    $  
income taxes                                                1,801
Add: Significant items - (benefit) charge    35            50
^(2)
Non-operating pension/OPEB costs               147           176
Less: Net exchange (losses) gains             11            (81)
Income from continuing operations before
income taxes, significant items, exchange
gains (losses), and non-operating              $  1,945    $  
pension/OPEB costs                                           2,108
Provision for income taxes on continuing       $    387   $   
operations                                                   392
Add: Tax benefits (expenses) on significant   55            18
items
 Tax benefits (expenses) on           48            58
non-operating pension/OPEB costs
 Tax benefits (expenses) on           (34)          37
exchange gains/losses
Provision for income taxes on operating        $    456   $   
earnings, excluding exchange gains (losses)                  505
Effective income tax rate                      21.8%         21.8%
Significant items effect and
non-operating pension/OPEB                     3.3%          1.3%
costs effect
Tax rate, from continuing operations, before
significant items and non-operating            25.1%         23.1%
pension/OPEB costs
Exchange gains (losses) effect                 (1.7%)        0.9%
Base income tax rate from                      23.4%         24.0%
continuing operations
(2) See Schedule B for detail of significant items.



SOURCE DuPont

Website: http://www.dupont.com
Contact: Media Contact: Michael Hanretta, 302-774-4005,
michael.j.hanretta@dupont.com; Investor Contact: 302-774-4994
 
Press spacebar to pause and continue. Press esc to stop.